Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(ENX: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Stories about
 
UPDATE 3-NORDIC STOCKS - Factors to watch on Nov 7
November 07, 2012
HELSINKI, Nov 7 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Wednesday: Read More
category companyNews
from Reuters: Company News
The Week in Review: China VC Investment to Hit a New High in 2010
November 13, 2010
“In 2010, venture capital investment in China life science will reach new highs,” said Greg Scott, CEO and Founder of ChinaBio® LLC, “reaching almost $700 million; Yunnan Walvax Biotech completed its... Read More
from ChinaBio® Today
Bayer Schering Partners with NPERC on Drug Delivery
November 09, 2010
Bayer Schering Pharma (XETRA: SCH) signed an agreement to conduct joint research on a biodegradable injection drug delivery system with the National Pharmaceutical Engineering Research Center. NPERC is... Read More
from ChinaBio® Today
The Week in Review: ChinaBio® Investor Forum Held in Tianjin
December 04, 2009
The 7th ChinaBio® Investor Forum granted “Most Promising Company” awards to Sinocro Medical of Tianjin, a medical device company, and vaccine company Tianjin CanSino Biotechnolo; Concord Medical... Read More
from ChinaBio® Today
Bayer Schering Receives SFDA Approval for MS Drug
December 02, 2009
Bayer Schering Pharma AG received SFDA approval of its Betaferon® (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis (MS). Bayer plans to launch Betaferon in China by... Read More
from ChinaBio® Today
The Week in Review: Partnerships and Financials
March 21, 2009
The ChinaBio® Partnering Forum, the first partnering forum for China life science, will be held in Shanghai in June 2009; Royal DSM made a $110 million investment into North China Pharmaceutical Group;... Read More
from ChinaBio® Today
Bayer Schering Will Build $129 Million Beijing R&D Center
February 12, 2009
Bayer Schering Pharma of Germany will invest $129 million to build a global R&D center located in Beijing. The investment will take place over five years. For Bayer Schering, China is the third largest... Read More
from ChinaBio® Today
Schwab Daily Average Trades Up 56% In Oct.
November 14, 2008
Schwab Daily Average Trades Up 56% In Oct. Read More
category Finance
from FOXBusiness.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here